全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Yuki Katayama , Eri Hosoyamada ...
来源:[J].International Journal of Pharmaceutics(IF 3.458), 2017, Vol.524 (1-2), pp.238-247
摘要:Abstract(#br)Reovirus induces tumor cell death efficiently and specifically, and thus is currently undergoing clinical testing as an anticancer agent. In the intracellular trafficking of reovirus, proteolytic disassembly of reovirus capsid-proteins and subsequent penetration...
作者:Yuki Katayama , Tadaaki Yamada ...
来源:[J].Thoracic Cancer(IF 0.65), 2019, Vol.10 (3), pp.526-532
摘要:Background Cancer immunotherapy is under development as a promising alternative strategy for treating advanced non‐small cell lung cancer (NSCLC). However, the development of novel biomarkers to optimize the use of immune checkpoint inhibitors (ICIs) is still ongoing. Gut mi...
作者:Yuki Katayama , Go Nagai ...
来源:[J].Scientific Reports(IF 2.927), 2019, Vol.9 (1), pp.1-13
摘要:Abstract The currently available haemoglobin A1c (HbA1c enzymatic assay consists of two specific steps: proteolysis of HbA1c and oxidation of the liberated fructosyl peptide by fructosyl peptide oxidase (FPOX. To develop a more convenient and high throughput assay, we devised nov...
作者:Yuki Katayama , Norihiko Kayahara ...
来源:[J].Analytical Biochemistry(IF 2.582), 2016, Vol.498, pp.29-36
摘要:Abstract(#br)Serum sphingomyelin (SM) has predictive value in the development of atherosclerosis. Furthermore, SM plays important roles in cell membrane structure, signal transduction pathways, and lipid raft formation. A convenient enzymatic method for SM is available for r...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×